Your browser doesn't support javascript.
loading
Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure.
Manouchehri, Navid; Salinas, Victor H; Rabi Yeganeh, Negar; Pitt, David; Hussain, Rehana Z; Stuve, Olaf.
Affiliation
  • Manouchehri N; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Salinas VH; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Rabi Yeganeh N; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Pitt D; Department of Neurology, Yale University, New Haven, CT, United States.
  • Hussain RZ; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Stuve O; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Front Neurol ; 13: 854390, 2022.
Article in En | MEDLINE | ID: mdl-35432156
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Front Neurol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Front Neurol Year: 2022 Type: Article Affiliation country: United States